Indeed, deletion or transcriptional silencing of p14ARF is frequent in ALL, while Mdm2 overexpression or silencing of the p53 transcriptional target p21CIP1 has been reported in approximately 50% of patients with ALL and linked with worse prognosis [28]. This evidence concerns the gene TP53 and acute lymphoblastic leukemia.